Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance.
- NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_assertion description "[Fumagillin is an inhibitor of type 2 methionine aminopeptidase that can block blood vessel formation, but its molecular mechanism and therapeutic value in colon cancer still remain to be elucidated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance.
- NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_assertion evidence source_evidence_literature NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance.
- NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_assertion SIO_000772 19563408 NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance.
- NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_assertion wasDerivedFrom befree-20140225 NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance.
- NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_assertion wasGeneratedBy ECO_0000203 NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP872553.RANxoqP5ouvBXF4MvvD1SYx6mtLjkIEKe36Pfc4Nru2d8130_provenance.